ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
about
Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer CellsInhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathwayWNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathwaysNew insights into the molecular pathogenesis of colorectal cancer.MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyRole of Wnt/β-catenin signaling in liver metabolism and cancerPlasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.Can genome engineering be used to target cancer-associated enhancers?Multiple genes of the renin-angiotensin system are novel targets of Wnt/β-catenin signaling.Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis.Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.Altering cancer transcriptomes using epigenomic inhibitorsInhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell LineThe evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapiesBeta-catenin-NF-κB interactions in murine hepatocytes: a complex to die for.Role of β-catenin-regulated CCN matricellular proteins in epithelial repair after inflammatory lung injury.Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.Role of Wnt canonical pathway in hematological malignancies.Cancer stem cells: a new framework for the design of tumor therapies.Drug discovery approaches to target Wnt signaling in cancer stem cells.β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target.Drugging Wnt signalling in cancerThe way Wnt works: components and mechanism.Novel drug discovery opportunities for colorectal cancer.Dissecting fibrosis: therapeutic insights from the small-molecule toolbox.Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases.Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.Wnt/beta-catenin pathway: modulating anticancer immune response.Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.Blockade of β-catenin signaling attenuates toluene diisocyanate-induced experimental asthma.Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle.β-Catenin Directs Nuclear Factor-κB p65 Output via CREB-Binding Protein/p300 in Human Airway Smooth Muscle.Inhibition of β-catenin/p300 interaction proximalizes mouse embryonic lung epithelium.
P2860
Q28269801-6C5B99B0-B38E-462C-B4D5-BA35AA7AF9D8Q28481465-A296EAE0-1B9C-4DB5-A919-320767C2E67DQ33572324-A345A209-91CB-442E-A550-85991A364187Q33597010-C2914536-F963-42F8-B122-7A8817FDB7ADQ33640592-DE17023C-F2A4-4867-BEA4-B554F24DA470Q33653982-7DCBD9AC-6837-4BC6-960C-54962384D668Q33940403-AB5C48AA-810D-41E9-A608-4699ED817BECQ34042645-87252303-DCB4-4C10-B569-3AC498C79764Q34652242-23B16D08-B33D-490D-BDA1-6CC65E6F49D2Q34787805-430F3816-C1D8-4E61-81B3-57AF29D82952Q35124213-F72932BE-B051-4D3D-AF81-DACBA8743C61Q35210196-90B8D0CD-92B8-44D4-A9E7-87862F1F993EQ35715788-C8D703F4-A41F-43D8-B4BA-143AFC286F57Q35863203-F4BEC6A6-7814-46C8-85A1-230D38899911Q36022772-D35067F7-A04D-415B-8327-19D6C57EBB04Q36515479-29E6B0E8-EBF5-4C6F-9F3C-00806E6E2982Q36592380-BCCA4FB2-E1FD-40FD-83F3-C286DD05E0ADQ36699998-610A4264-EBC0-48CD-83A5-1B16E48F2019Q37364008-C8150D2C-F3E8-40EA-97D8-12C9F53A4A83Q37789052-5F98CA48-FA79-46C2-886B-B07498DB15B9Q37796629-72E7F57C-CE79-4B61-9F18-61F71186D2E2Q37840943-EB91007D-04CF-4BF3-AF23-F5C8414834F3Q37925433-0D958036-F56C-45D3-960D-92D798360706Q38012254-ADFCED8E-1987-4C25-8D96-1B0C26DCC30EQ38068918-97D99744-00B9-4C06-9801-E8B371304658Q38114502-D665CD64-1880-483D-A3D8-F87AB39EC476Q38580461-D51E9BBA-83A4-4BF9-8D4F-6B1FB8A4950AQ38675876-197CB92E-02DF-4A19-9565-20A5EA359B63Q38734645-4562E845-A3A2-4230-812F-05D230D50CFDQ38794338-171A3B52-AD2F-431B-8D26-C5354566EEE8Q38892306-3305DEC5-EA3B-45EF-9E7C-8C5997613D46Q38908764-12D804C8-E9DA-4693-9E41-F9C144B5B641Q39037684-6B589134-E6B5-475B-BA3D-C565242F73BDQ39097271-14BE9D77-4129-4756-A0EC-0A5BD1BD0CB8Q39286193-022484DF-D3EB-4A26-B1DC-BD5852FFEF56Q39298930-89911E16-811E-4A4D-8643-B5235012FE8DQ39614255-C2ED17E4-FF4D-4170-8566-A98F6B0A4C91Q40485763-2F9E3D82-3F27-4D04-94E4-CA5FE08ABC12Q41699533-7E6D099C-8E56-41F2-A4AE-9CCB8D8097E1Q42151507-F40CCF75-239D-4BA6-861B-6EF2100B2F28
P2860
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@ast
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@en
type
label
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@ast
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@en
prefLabel
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@ast
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@en
P2093
P356
P1433
P1476
ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
@en
P2093
Masakatsu Eguchi
Michael Kahn
Sung Chan Lee
P304
P356
10.2174/1573406054864098
P577
2005-09-01T00:00:00Z